Charles River Laboratories Comprehensive Income 2010-2024 | CRL
Charles River Laboratories comprehensive income for the quarter ending September 30, 2024 was $-0.193B, a 28.05% decline year-over-year.
- Charles River Laboratories comprehensive income for 2023 was $-0.196B, a 25.04% decline from 2022.
- Charles River Laboratories comprehensive income for 2022 was $-0.262B, a 59.07% increase from 2021.
- Charles River Laboratories comprehensive income for 2021 was $-0.165B, a 18.63% increase from 2020.